{"filing":{"accession_number":"0001104659-26-064545","cik":"0001374339","ticker":"PMN","company_name":"ProMIS Neurosciences Inc.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"pmn-20260520x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/pmn-20260520x8k.htm"},"events":[{"id":9741,"run_id":8539,"accession_number":"0001104659-26-064545","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"ProMIS Neurosciences held its Annual Meeting on May 20, 2026, with shareholders voting on three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan increasing the share pool by 900,000 Common Shares. Detailed voting results were disclosed for each proposal.","company_name":"ProMIS Neurosciences Inc.","ticker":"PMN","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":530,"accession_number":"0001104659-26-064545","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2025 Stock Option and Incentive Plan that increases the share pool available for issuance by 900,000 Common Shares. This is a compensatory arrangement amendment affecting equity grants to officers and directors, which falls squarely within exec_compensation. The materiality is supported by the substantial increase in authorized shares for equity compensation purposes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:30.782827+00:00","company_name":"","ticker":null,"filing_date":""},{"id":531,"accession_number":"0001104659-26-064545","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from ProMIS Neurosciences' Annual Meeting held on May 20, 2026, covering three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 disclosure and constitutes material information affecting governance and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:30.782827+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":530,"accession_number":"0001104659-26-064545","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2025 Stock Option and Incentive Plan that increases the share pool available for issuance by 900,000 Common Shares. This is a compensatory arrangement amendment affecting equity grants to officers and directors, which falls squarely within exec_compensation. The materiality is supported by the substantial increase in authorized shares for equity compensation purposes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:30.782827+00:00","company_name":"ProMIS Neurosciences Inc.","ticker":"PMN","filing_date":"2026-05-20"},{"id":531,"accession_number":"0001104659-26-064545","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from ProMIS Neurosciences' Annual Meeting held on May 20, 2026, covering three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 disclosure and constitutes material information affecting governance and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:43:30.782827+00:00","company_name":"ProMIS Neurosciences Inc.","ticker":"PMN","filing_date":"2026-05-20"}]}